X-18647303-C-T

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong

The NM_000330.4(RS1):​c.214G>A​(p.Glu72Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000455 in 1,097,695 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000046 ( 0 hom. 1 hem. )

Consequence

RS1
NM_000330.4 missense

Scores

9
5
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:16O:1

Conservation

PhyloP100: 7.57
Variant links:
Genes affected
RS1 (HGNC:10457): (retinoschisin 1) This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM1
In a domain F5/8 type C (size 156) in uniprot entity XLRS1_HUMAN there are 39 pathogenic changes around while only 0 benign (100%) in NM_000330.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.984
PP5
Variant X-18647303-C-T is Pathogenic according to our data. Variant chrX-18647303-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 9888.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-18647303-C-T is described in Lovd as [Pathogenic]. Variant chrX-18647303-C-T is described in Lovd as [Likely_pathogenic]. Variant chrX-18647303-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RS1NM_000330.4 linkc.214G>A p.Glu72Lys missense_variant Exon 4 of 6 ENST00000379984.4 NP_000321.1 O15537
RS1XM_047442337.1 linkc.118G>A p.Glu40Lys missense_variant Exon 2 of 4 XP_047298293.1
CDKL5NM_001037343.2 linkc.2797+1213C>T intron_variant Intron 20 of 21 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.2797+1213C>T intron_variant Intron 19 of 20 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RS1ENST00000379984.4 linkc.214G>A p.Glu72Lys missense_variant Exon 4 of 6 1 NM_000330.4 ENSP00000369320.3 O15537
CDKL5ENST00000379989.6 linkc.2797+1213C>T intron_variant Intron 20 of 21 1 ENSP00000369325.3 O76039-1
CDKL5ENST00000379996.7 linkc.2797+1213C>T intron_variant Intron 19 of 20 1 ENSP00000369332.3 O76039-1
RS1ENST00000476595.1 linkn.705G>A non_coding_transcript_exon_variant Exon 3 of 5 1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD3 exomes
AF:
0.0000109
AC:
2
AN:
183440
Hom.:
0
AF XY:
0.0000147
AC XY:
1
AN XY:
67872
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000524
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000455
AC:
5
AN:
1097695
Hom.:
0
Cov.:
30
AF XY:
0.00000275
AC XY:
1
AN XY:
363121
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000185
Gnomad4 FIN exome
AF:
0.0000493
Gnomad4 NFE exome
AF:
0.00000238
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
22
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:16Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Juvenile retinoschisis Pathogenic:7
Feb 05, 2025
SingHealth Duke-NUS Institute of Precision Medicine
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

xperimental studies have shown that this missense change affects RS1 function (PS3, PMID: 20809529;20061330). REVEL score is 0.921 (PP3_mod). This variant is located in a mutational hotspot where >50% of variants are pathogenic (PM1) Other changes at this amino acid residue have been classified as pathogenic (PM5, p.Glu72Gln; p.Glu72Val; p.Glu72Lys; p.Glu72Gly). RS1 mutations are specific to retinoschisis phenotypes (PP4) -

Nov 15, 2019
Myriad Genetics, Inc.
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

NM_000330.3(RS1):c.214G>A(E72K) is classified as pathogenic in the context of X-linked juvenile retinoschisis. Sources cited for classification include the following: PMID 20061330, 10922205, 618178, 19390641, 10533068, 10234514 and 20809529. Classification of NM_000330.3(RS1):c.214G>A(E72K) is based on the following criteria: This is a well-established pathogenic variant in the literature that has been observed more frequently in patients with clinical diagnoses than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. -

Mar 19, 2024
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 01, 1998
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Nov 28, 2019
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PM5,PP2,PP3,PP4. This variant was detected in hemizygous state. -

Jun 23, 2023
3billion
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Predicted Consequence/Location: The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.92; 3Cnet: 0.96). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009888 /PMID: 9618178). Different missense changes at the same codon (p.Glu72Asp, p.Glu72Gln, p.Glu72Gly, p.Glu72Val) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009889, VCV000098916, VCV000992968, VCV001994509 /PMID: 11295123, 17631851, 28272453, 9618178). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -

Jul 11, 2024
Institute of Human Genetics, University of Leipzig Medical Center
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Criteria applied: PS3,PS4,PM5_STR,PM2_SUP,PP3,PP4 -

not provided Pathogenic:6Other:1
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Retina International
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

-
Clinical Genetics, Academic Medical Center
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 72 of the RS1 protein (p.Glu72Lys). This variant is present in population databases (rs104894928, gnomAD 0.01%). This missense change has been observed in individuals with X-linked retinoschisis (PMID: 9618178, 28272453, 30652005). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 9888). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RS1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RS1 function (PMID: 20809529). This variant disrupts the p.Glu72 amino acid residue in RS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9618178, 28272453). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

RS1: PS4, PM1, PM2, PM5, PP3, PP4 -

Oct 20, 2021
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Published functional studies demonstrate a damaging effect with misfolding of the discoidin domain, which results in the formation of high molecular mass aggregates in the cell (Vijayasarathy et al., 2010); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10234514, 31087526, 20809529, 20061330, 27788217, 23288992, 22245536, 19324861, 22245991, 29081674, 27798099, 9618178, 30652005, 33781268, 33460243) -

Retinal dystrophy Pathogenic:2
Feb 22, 2019
Blueprint Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 01, 2023
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Pathogenic:1
Sep 20, 2022
Ambry Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.214G>A (p.E72K) alteration is located in exon 4 (coding exon 4) of the RS1 gene. This alteration results from a G to A substitution at nucleotide position 214, causing the glutamic acid (E) at amino acid position 72 to be replaced by a lysine (K). Based on data from gnomAD, the A allele has an overall frequency of 0.001% (2/183440) total alleles studied. The highest observed frequency was 0.006% (1/16007) of European (Finnish) alleles. This variant is a common founder mutation and has been detected in individuals with X-linked juvenile retinoschisis (The Retinoschisis Consortium, 1998; Hiriyanna, 1999; Huopaniemi, 1999; Eksandh, 2000; Riveiro-Alvarez, 2009; Kim, 2009; Skorczyk, 2012; Wang, 2016; Hu, 2017; Sudha, 2018; Avela, 2019; Kondo, 2019; Huang, 2020; Bai, 2021; Hahn, 2022; Bender, 2022). This amino acid position is highly conserved in available vertebrate species. Functional and structural analysis suggest this alteration disrupts the local structure, but does not significantly impair secretion of the mutant protein (Wu, 2003; Sergeev, 2010; Vijayasarathy, 2010). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.92
BayesDel_addAF
Pathogenic
0.53
D
BayesDel_noAF
Pathogenic
0.67
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.64
D
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.71
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.2
M
PrimateAI
Uncertain
0.78
T
PROVEAN
Uncertain
-3.6
D
REVEL
Pathogenic
0.92
Sift
Benign
0.26
T
Sift4G
Benign
0.089
T
Polyphen
1.0
D
Vest4
0.96
MutPred
0.90
Gain of ubiquitination at E72 (P = 0.0101);
MVP
1.0
MPC
1.7
ClinPred
0.85
D
GERP RS
5.4
Varity_R
0.83
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104894928; hg19: chrX-18665423; API